Dasatinib-induced colitis: clinical, endoscopic and histological findings-Reference-Cited by-同舟云学术

Dasatinib-induced colitis: clinical, endoscopic and histological findings

Published:2022-01-01 Issue:4 Volume:57 Page:449-456
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Yamauchi Kenji¹^ORCID,Inaba Tomoki¹,Colvin Hugh Shunsuke¹,Sakakihara Ichiro¹,Yamamoto Kumiko¹,Izumikawa Koichi¹,Takahashi Sakuma¹,Tanaka Shigetomi¹,Ishikawa Shigenao¹,Wato Masaki¹,Ando Midori²,Waki Masato³

Affiliation:

1. Department of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan

2. Department of Pathology, Kagawa Prefectural Central Hospital, Takamatsu, Japan

3. Department of Hematology, Kagawa Prefectural Central Hospital, Takamatsu, Japan

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2021.2022190

Reference19 articles.

1. Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

2. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

3. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

4. Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib

5. Cytomegalovirus pulls strings behind NK cells

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer;Drug Resistance Updates;2024-03

2. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo;Revista de Gastroenterología de México;2024-01

3. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist;Revista de Gastroenterología de México (English Edition);2024-01

4. Ruscogenin ameliorates dasatinib-induced intestinal barrier dysfunction via ErbB4/YAP and ROCK/MLC pathways;Journal of Natural Medicines;2023-06-22

5. Clinical uses and safety concerns of tyrosine kinase inhibitors with a focus on novel drugs: A narrative review;Journal of Oncology Pharmacy Practice;2023-05-12